Oncura

R-Bendamustine: what to expect, day by day

NHL - Follicular28-day cycle8 effects documented

An every-4-week pair for indolent (slow-growing) lymphoma, often chosen partly because it causes little hair loss. Expect lowered blood counts (low point around week 3) and nausea. Because it lowers immune cells for months, your team usually prescribes preventive antibiotics/antivirals — take them as directed.

Rituximab + bendamustine every 4 weeks. Blood-count drops are nadir-based (nadir around week 3). A signature feature is DEEP, PROLONGED lymphopenia (low immune T-cells for months → risk of unusual/opportunistic infections), so preventive antibiotics/antivirals are commonly used. Notably causes much LESS hair loss than R-CHOP.

Get help straight away — this is true on any regimen, on any day.

A temperature of 100.4°F (38°C) or higher during treatment can mean a serious infection while your blood counts are low. Call your team or go to the ER — do not wait it out.

Also urgent: trouble breathing or chest pain · swelling of the face, lips or throat · new confusion or fainting · shaking chills · not being able to keep fluids down.

This is standing guidance shown to everyone. Nothing on this page is based on anything about you, and nobody is monitoring you.

Timed to the cycle

Day 1 is the day of your infusion. These are the effects a retrievable document ties to a day range for this regimen — not a prediction about you.

Infusion reaction (rituximab)

During or just after an infusion

A reaction during the first rituximab infusion (chills, fever, flushing) — less likely on later infusions. You'll be pre-medicated and watched.

Call your team urgently: Any trouble breathing, throat tightness, or dizziness during the infusion — tell staff at once.

reported by about 77% first infusion (mostly mild) of people · Timing is part of what this effect is · from Rituximab

Neutropenia

Typically around days 14–21

A temporary drop in infection-fighting white cells, with the low point usually around week 3. Your team checks counts and may delay the next cycle or give a booster.

Call your team urgently: A temperature of 100.4°F (38.0°C) or higher — an emergency.

reported by about 86% of people; severe in 60% · Timing from the manufacturer’s prescribing information · from Bendamustine

Thrombocytopenia

Typically around days 14–21

A drop in platelets (which help blood clot), lowest around week 3. Watch for easy bruising or bleeding.

Call your team: Bleeding that won't stop, or black/tarry stools.

reported by about 86% of people; severe in 25% · Timing from the manufacturer’s prescribing information · from Bendamustine

Anemia

Typically around days 14–21

A drop in red cells causing tiredness and breathlessness, building over cycles.

Call your team: New or worsening breathlessness or a racing heart.

reported by about 88% of people; severe in 11% · Timing from the manufacturer’s prescribing information · from Bendamustine

Not tied to a cycle day

These build with the number of doses, or are measured from when treatment started, so a cycle day would be the wrong shape for them. Each keeps the timing its own source states.

Prolonged low immune cells (lymphopenia) with infection risk

deep, prolonged (months); recovers slowly

Bendamustine lowers immune T-cells deeply and for months, which raises the risk of unusual ('opportunistic') infections and reactivation of viruses like shingles. That's why preventive antibiotics/antivirals are commonly prescribed — take them as directed and report any fever or new symptoms.

Call your team urgently: Fever, breathlessness, or a painful blistering rash — contact your team.

reported by about 99% lymphopenia of people; severe in 94% · from Bendamustine

Nausea and vomiting

Sickness in the first 24 hours is the "acute" phase and usually peaks 2-3 hours in; anything from 24 to 120 hours is the "delayed" phase.

Usually controlled with anti-nausea medicine given before treatment.

Call your team: Can't keep fluids down for more than 12 hours.

reported by about 75% nausea (vomiting 40%) of people; severe in 4% · Timing from a clinical guideline · from Bendamustine

Rash / skin reaction

early; may progress with continued treatment

A skin rash that can occasionally become severe (rarely serious blistering reactions). Report a spreading rash, blisters, or peeling — especially with mouth/eye involvement — early.

Call your team urgently: Spreading rash, blisters, or peeling — especially with mouth/eye sores — seek care.

reported by about 16% of people; severe in <1% · from Bendamustine

Fatigue

Tiredness that builds through the cycles and usually improves afterward.

reported by about 57% of people; severe in 11% · from Bendamustine

Where this comes from

S1. Bendamustine (Treanda) FDA label, indolent NHL cohort (n=176) — FDA label
S2. Rituximab (Rituxan) FDA label (infusion reactions, HBV, TLS) — FDA label
S3. Rummel MJ, StiL NHL1 (B-R vs R-CHOP) (2013) — PMID 23433739

Timing windows on this page rest on:

Treanda (bendamustine) FDA prescribing information — “Hematologic nadirs were observed predominantly in the third week of therapy” source
MASCC/ESMO antiemetic consensus — emesis phases — “acute 0-24 h, delayed 25-120 h, overall 0-120 h” source
Definitional — an infusion reaction is one that occurs during or shortly after the infusion — “The timing is part of what the term denotes; there is no empirical claim here to source.”
NCI PDQ — Fatigue (health professional) — “five distinct trajectories ... significant interindividual variability” source

A window appears here only where a retrievable document ties it to a drug in this regimen. Where nothing could be found, the window was removed rather than estimated — so a missing time is an honest gap, not an oversight.

Track your own cycle in Oncura →

Free, no account, nothing leaves your device.